Evaluation of GLUT1 variation in non-acquired focal epilepsy.

2017-07

Peeraer, Alexander

Damiano, John A

Bellows, Susannah T

Scheffer, Ingrid E

Berkovic, Samuel F

Mullen, Saul A

Hildebrand, Michael S

GLUT1 deficiency

SLC2A1 gene

glucose transporter 1

non-acquired focal epilepsy

Journal Article

0000-0002-2311-2174

0000-0003-4580-841X

0000-0003-2739-0515

10.1016/j.eplepsyres.2017.04.007

Brain glucose transport is dependent on glucose transporter 1 (GLUT1), encoded by the solute carrier family 2 member 1 (SLC2A1) gene. Mutations in SLC2A1 cause GLUT1 deficiency which is characterized by a broad spectrum of neurological phenotypes including generalized epilepsy, motor disorders, developmental delay and microcephaly. Recent case reports suggest SLC2A1 mutations can contribute to non-acquired focal epilepsy (NAFE) but interrogation of a large patient cohort has not been reported. We studied 200 patients with NAFE (126 with temporal lobe epilepsy) comprising 104 females and 96 males with a mean age of onset of 18 years. Polymerase chain reaction (PCR) and Sanger sequencing was performed to detect variants in all 10 coding exons and splice site regions of the SLC2A1 gene. We did not detect any pathogenic mutations in SLC2A1 in this cohort. Our data suggests that the frequency of GLUT1 mutations in NAFE is low. Limitations of this study include the mean age of onset and cohort size. Future research should focus on subpopulations of focal epilepsy with lower age of seizure onset particularly with co-existent movement disorders in which GLUT1 mutations may play a more important role.

link

Epilepsy research 2017; 133: 54-57

Epilepsy research